Second RAS Symposium Brings Together World’s Leading RAS Scientists

From December 6–8, the Advanced Technology Research Facility of the Frederick National Laboratory for Cancer Research was abuzz with conversation and collaboration as nearly 450 scientists, academics, and industry partners gathered for the Second RAS Initiative Symposium. Attendees hailed from 14 nations, dozens of institutions, and diverse scientific backgrounds, but they shared a common purpose: to present and discuss their research on RAS genes and cancer.

Tags: 

Operations and Maintenance December Newsletter

Our first consideration in every task, large or small, is the safety of our O&M work force and our customers. You, our customer, play an important role in the execution of your work order. The support you provide assists us in understanding the work order requirements, which is the first step in developing a safe plan for accomplishing your request.

Tags: 

NCI Helps Children’s Hospital of Philadelphia to Identify and Treat New Target in Pediatric Cancer

There may be a new, more effective method for treating high-risk neuroblastoma, according to scientists at the Children’s Hospital of Philadelphia and collaborators in the Cancer and Inflammation Program at NCI at Frederick. Together, the groups published a study describing a previously unrecognized protein on neuroblastoma cells, called GPC2, as well as the creation of a novel antibody-drug conjugate, a combination of a human antibody and a naturally occurring anticancer drug, that locates and binds to GPC2 in a highly efficient way.

Tags: 

Pages

Subscribe to Poster RSS